- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Accelerated single cell seeding in relapsed multiple myeloma ; volume:11 ; number:1 ; day:17 ; month:7 ; year:2020 ; pages:1-10 ; date:12.2020
Nature Communications ; 11, Heft 1 (17.7.2020), 1-10, 12.2020
- Urheber
-
Landau, Heather J.
Yellapantula, Venkata
Diamond, Benjamin T.
Rustad, Even H.
Maclachlan, Kylee H.
Gundem, Gunes
Medina-Martinez, Juan
Ossa, Juan Arango
Levine, Max F.
Zhou, Yangyu
Kappagantula, Rajya
Baez, Priscilla
Attiyeh, Marc
Makohon-Moore, Alvin
Zhang, Lance
Boyle, Eileen M.
Ashby, Cody
Blaney, Patrick
Patel, Minal
Zhang, Yanming
Dogan, Ahmet
Chung, David J.
Giralt, Sergio
Lahoud, Oscar B.
Peled, Jonathan U.
Scordo, Michael
Shah, Gunjan
Hassoun, Hani
Korde, Neha S.
Lesokhin, Alexander M.
Lu, Sydney
Mailankody, Sham
Shah, Urvi
Smith, Eric
Hultcrantz, Malin L.
Ulaner, Gary A.
Rhee, Frits van
Morgan, Gareth J.
Landgren, Ola
Papaemmanuil, Elli
Iacobuzio-Donahue, Christine
Maura, Francesco
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-17459-z
- URN
-
urn:nbn:de:101:1-2021031418095619276641
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Landau, Heather J.
- Yellapantula, Venkata
- Diamond, Benjamin T.
- Rustad, Even H.
- Maclachlan, Kylee H.
- Gundem, Gunes
- Medina-Martinez, Juan
- Ossa, Juan Arango
- Levine, Max F.
- Zhou, Yangyu
- Kappagantula, Rajya
- Baez, Priscilla
- Attiyeh, Marc
- Makohon-Moore, Alvin
- Zhang, Lance
- Boyle, Eileen M.
- Ashby, Cody
- Blaney, Patrick
- Patel, Minal
- Zhang, Yanming
- Dogan, Ahmet
- Chung, David J.
- Giralt, Sergio
- Lahoud, Oscar B.
- Peled, Jonathan U.
- Scordo, Michael
- Shah, Gunjan
- Hassoun, Hani
- Korde, Neha S.
- Lesokhin, Alexander M.
- Lu, Sydney
- Mailankody, Sham
- Shah, Urvi
- Smith, Eric
- Hultcrantz, Malin L.
- Ulaner, Gary A.
- Rhee, Frits van
- Morgan, Gareth J.
- Landgren, Ola
- Papaemmanuil, Elli
- Iacobuzio-Donahue, Christine
- Maura, Francesco
- SpringerLink (Online service)
Ähnliche Objekte (12)
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma